05-23-0600 Sigma-AldrichSubstance P - CAS 33507-63-0 - Calbiochem
Neuropeptide found in high concentrations in the gut.
More>> Neuropeptide found in high concentrations in the gut. Less<<Synonymes: RPKPQQFFGLM
Produits recommandés
Aperçu
| Replacement Information |
|---|
Tableau de caractéristiques principal
| CAS # | Empirical Formula |
|---|---|
| 33507-63-0 | C₆₃H₉₈N₁₈O₁₃S |
Prix & Disponibilité
| Référence | Disponibilité | Conditionnement | Qté | Prix | Quantité | |
|---|---|---|---|---|---|---|
| 05-23-0600-1MG |
|
Ampoule plast. | 1 mg |
|
— | |
| 05-23-0600-25MG |
|
Ampoule plast. | 25 mg |
|
— | |
| 05-23-0600-5MG |
|
Ampoule plast. | 5 mg |
|
— |
| Product Information | |
|---|---|
| CAS number | 33507-63-0 |
| ATP Competitive | N |
| Form | White solid |
| Formulation | Supplied as a trifluoroacetate salt. |
| Hill Formula | C₆₃H₉₈N₁₈O₁₃S |
| Chemical formula | C₆₃H₉₈N₁₈O₁₃S |
| HS Code | 2937 19 90 |
| Hygroscopic | Hygroscopic |
| Reversible | N |
| Sold on the basis of peptide content | Y |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | Substance P receptors |
| Purity | ≥96% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | N |
| Peptide Content | Y |
| Peptide Sequence | H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH₂ |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Référence | GTIN |
| 05-23-0600-1MG | 04055977207019 |
| 05-23-0600-25MG | 04055977207026 |
| 05-23-0600-5MG | 04055977207033 |
Documentation
Substance P - CAS 33507-63-0 - Calbiochem FDS
| Titre |
|---|
Substance P - CAS 33507-63-0 - Calbiochem Certificats d'analyse
| Titre | Numéro de lot |
|---|---|
| 05-23-0600 |
Références bibliographiques
| Aperçu de la référence bibliographique |
|---|
| Roush, E.D., and Kwatra, M.M. 1998. FEBS Lett. 428, 291. Chiwakata, C.B., et al. 1996. Infect. Immun. 64, 5106. Tanabe, T., et al. 1996. Eur. J. Pharmacol. 299, 187. Heath, M.J., et al. 1994. J. Neurophysiol. 72, 1192. Zhu, J., et al. 1994. Eur. J. Pharmacol. 268, 279. Garland, A.M., et al. 1993. Soc. Neurosci. 19, Abstract 104.6. Wei, J.Y., et al. 1993. Soc. Neurosci. 19, Abstract 136.14. |



